{"id":301161,"date":"2026-10-12T10:35:41","date_gmt":"2026-10-12T05:05:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=301161"},"modified":"2026-10-12T10:35:41","modified_gmt":"2026-10-12T05:05:41","slug":"tcs-hdfc-life-cipla-which-stock-to-buy-and-sell-target-price-stop-loss-brokerage-views","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/tcs-hdfc-life-cipla-which-stock-to-buy-and-sell-target-price-stop-loss-brokerage-views\/","title":{"rendered":"TCS HDFC Life Cipla: Which Stock to Buy and Sell? Brokerage Targets, Technical Levels, Stop-Loss Ideas, Valuation and Risks for Three Stocks Down Sharply in 2026"},"content":{"rendered":"

TCS about Rs 2,086, targets Rs 1,578 to Rs 3,266. HDFC Life: SMC buy above Rs 567, target Rs 608-610, stop Rs 530. Cipla about Rs 1,296, Macquarie Buy target Rs 1,730. Q2 results: Cipla 27 Oct.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

TCS HDFC Life Cipla is a question with three different answers, because each stock is down sharply in 2026 for a different reason and brokerages are split on all three. SMC Global has a conditional buy on HDFC Life above Rs 567 with a target of Rs 608 to Rs 610 and a stop-loss of Rs 530, Macquarie has a Buy on Cipla with a target of Rs 1,730 against a price near Rs 1,296, and TCS targets span Rs 1,578 to Rs 3,266 around a price of about Rs 2,086. The evidence favours a selective view, with HDFC Life offering a defined technical setup, Cipla a margin recovery story that Q2 results on 27 October must confirm, and TCS a stock where Morgan Stanley and CLSA are neutral and targets run from well below to far above the price. No stock is a clear sell on this data, so the realistic choice is to buy on confirmation, hold or avoid, and this is not a recommendation.<\/p>\n<\/p><\/div>\n

TCS HDFC Life Cipla is an unusual trio because the stocks sit in IT services, life insurance and pharma, so they respond to different drivers, and each can appear on stocks to buy lists for different reasons: global tech demand, interest rates and insurance margins, and US generics and margins. TCS has fallen about 35% in 2026 and HDFC Life about 31%, while Cipla is about 22% below its 52-week high.<\/p>\n

If you are weighing TCS HDFC Life Cipla for a portfolio, this article covers each stock’s price and trend, the brokerage targets, the technical levels and stop-loss ideas that analysts have published, a side-by-side comparison, scenarios, the risks and what to watch.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n